Clarithromycin Dosing for Recurrent Tonsillitis
For recurrent bacterial tonsillitis, clarithromycin should be dosed at 7.5 mg/kg twice daily (maximum 250 mg per dose) for 10 days in children, or 250 mg twice daily in adults for 10 days, but only if the patient has a documented penicillin allergy—otherwise, penicillin or amoxicillin should be used as first-line therapy. 1
Key Dosing Parameters
Standard Dosing (Immediate-Release)
- Children: 7.5 mg/kg/dose twice daily (maximum 250 mg/dose) for 10 days 1
- Adults: 250 mg twice daily for 10 days 1
Extended-Release Formulation
The extended-release formulation is not indicated for pharyngitis/tonsillitis. It is only FDA-approved for acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, and community-acquired pneumonia in adults 2
Critical Clinical Context
When to Use Clarithromycin
Clarithromycin is recommended only for patients with documented penicillin allergy 1. The IDSA guidelines give this a "strong, moderate" recommendation strength, which is notably weaker than the "strong, high" recommendation for penicillin or amoxicillin in non-allergic patients.
Major Limitation: Macrolide Resistance
Resistance of Group A Streptococcus (GAS) to clarithromycin is well-known and varies geographically and temporally 1. Research demonstrates that clarithromycin fails to eradicate clarithromycin-resistant GAS isolates, with eradication rates as low as 14-19% in resistant strains compared to 74-83% in susceptible strains 3. In areas where macrolide resistance exceeds 10%, clarithromycin should be avoided entirely.
Recurrent Tonsillitis Considerations
Definition and Surgical Threshold
Recurrent tonsillitis is defined as:
- ≥7 adequately treated episodes in the preceding year, OR
- ≥5 episodes in each of the preceding 2 years, OR
- ≥3 episodes in each of the preceding 3 years 4
Tonsillectomy is not recommended solely to reduce the frequency of GAS pharyngitis according to IDSA guidelines (strong, high recommendation) 1. However, when the above thresholds are met, tonsillectomy becomes highly effective 4.
Alternative Antibiotics for Recurrent Cases
For patients with true recurrent tonsillitis who have contraindications to tonsillectomy, evidence suggests that clindamycin or amoxicillin-clavulanate are superior to penicillin in preventing future episodes and eradicating bacteria 5. These agents may be more effective than clarithromycin in the recurrent setting due to better coverage of beta-lactamase producing organisms and anaerobes present in tonsillar crypts 6.
Important Caveats
Dosage Adjustments Required
- Severe renal impairment (CrCl <30 mL/min): Reduce dose by 50% 2
- Moderate renal impairment with atazanavir/ritonavir: Reduce dose by 50% 2
- Severe renal impairment with atazanavir/ritonavir: Reduce dose by 75% 2
Contraindications
Clarithromycin is contraindicated in patients with:
- History of cholestatic jaundice or hepatic dysfunction with prior clarithromycin use 2
- QT prolongation or risk factors for torsades de pointes 2
- Concurrent use of cisapride, pimozide, lomitapide, lovastatin, or simvastatin 2
Administration
- Take with food (for extended-release formulation) 2
- Immediate-release can be taken without regard to meals
- Complete the full 10-day course even if symptoms improve
Clinical Algorithm
- Confirm diagnosis: Use Centor, McIsaac, or FeverPAIN score; perform rapid strep test if indicated 4
- Assess penicillin allergy: True IgE-mediated allergy required for clarithromycin use
- Check local resistance patterns: If macrolide resistance >10%, choose alternative (cephalexin or clindamycin)
- Prescribe appropriate regimen: 7.5 mg/kg BID × 10 days (peds) or 250 mg BID × 10 days (adults)
- Document episodes: Track frequency for potential tonsillectomy indication
- Consider tonsillectomy: If meets threshold criteria (≥7/year, ≥5/year × 2 years, or ≥3/year × 3 years)